Juan Badimon

Director, Atherothrombosis Research Unit · Icahn School of Medicine at Mount Sinai

Credentials: ·

History

Atherothrombosis Research Unit · Icahn School of Medicine at Mount Sinai
2001–Present
Icahn School of Medicine at Mount Sinai · Icahn School of Medicine
Present

Targeting Platelets in Chronic HIV Infection
National Heart, Lung, and Blood Institute · R56
PI · $760.3K · Icahn School of Medicine at Mount Sinai
2015–2017
Translational Studies of Depression, Platelets, & CAD
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.5M · Icahn School of Medicine at Mount Sinai
2002–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $88.4K · Icahn School of Medicine at Mount Sinai
1997–2008
Tissue Factor, Thrombosis and the Arterial Wall
National Heart, Lung, and Blood Institute · P50
Project lead · $2.1M · Icahn School of Medicine at Mount Sinai
1996–2006

Antithrombotic Activities of Sotagliflozin vs. Empagliflozin
Principal investigator · Completed · Phase 4
Icahn School of Medicine at Mount Sinai
2025–2026
Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients
Principal investigator · Completed · Phase 4
Juan Badimon
2022–2025
Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).
Principal investigator · Completed · Phase 4
Icahn School of Medicine at Mount Sinai
2018–2020
Targeting Platelets in Chronic HIV Infection
Principal investigator · Completed · Phase 2
Icahn School of Medicine at Mount Sinai
2015–2016